Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001434265-25-000078
Filing Date
2025-09-23
Accepted
2025-09-23 10:56:00
Documents
13
Period of Report
2025-09-23

Document Format Files

Seq Description Document Type Size
1 6-K gmab_20250923xx6k.htm 6-K 14119
2 EX-99.1 gmab_20250923xxex99d1.htm EX-99.1 15629
3 GRAPHIC genmab_logoa.jpg GRAPHIC 57250
4 EX-99.2 gmab_20250923xxex99d2.htm EX-99.2 16584
5 GRAPHIC gmab_20250923xxex99d2001.jpg GRAPHIC 128951
6 GRAPHIC gmab_20250923xxex99d2002.jpg GRAPHIC 103542
7 GRAPHIC gmab_20250923xxex99d2003.jpg GRAPHIC 120342
8 GRAPHIC gmab_20250923xxex99d2004.jpg GRAPHIC 94957
9 GRAPHIC gmab_20250923xxex99d2005.jpg GRAPHIC 93165
10 GRAPHIC gmab_20250923xxex99d2006.jpg GRAPHIC 113886
11 GRAPHIC gmab_20250923xxex99d2007.jpg GRAPHIC 100008
12 GRAPHIC gmab_20250923xxex99d2008.jpg GRAPHIC 223370
13 GRAPHIC gmab_20250923xxex99d2009.jpg GRAPHIC 132546
  Complete submission text file 0001434265-25-000078.txt   1653318
Mailing Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
Business Address TOLDBODGADE 33 1253 COPENHAGEN K G7 00000
GENMAB A/S (Filer) CIK: 0001434265 (see all company filings)

EIN.: 000000000
Type: 6-K | Act: 34 | File No.: 001-38976 | Film No.: 251332214
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)